Cargando…

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study [Corrigendum]

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343748/ https://www.ncbi.nlm.nih.gov/pubmed/30718948 http://dx.doi.org/10.2147/COPD.S194429

Ejemplares similares

Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study
por: Casas, Alejandro, et al.
Publicado: (2018)

Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study
por: Montes de Oca, Maria, et al.
Publicado: (2017)

Corrigendum to “Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country”
por: Duran, Carlos E., et al.
Publicado: (2020)

The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes [Corrigendum]
Publicado: (2019)

Adapting Inhaled Medication Practice in COPD and Asthma to Avoid Funding the Tobacco Industry [Corrigendum]
Publicado: (2021)

The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies [Corrigendum]
Publicado: (2020)

Predicting frequent COPD exacerbations using primary care data [Corrigendum]
Publicado: (2018)

COPD management costs according to the frequency of COPD exacerbations in UK primary care [Corrigendum]
Publicado: (2014)

Bronchiectasis in COPD patients: more than a comorbidity? [Corrigendum]
Publicado: (2019)

Corrigendum to “Recommendations for Diagnosis and Management of Osteoporosis in COPD Men”
por: Mazokopakis, Elias E., et al.
Publicado: (2017)

Antimicrobial stewardship programs in seven Latin American countries: facing the challenges
por: Pallares, Christian José, et al.
Publicado: (2023)

Russian guidelines for the management of COPD: algorithm of pharmacologic treatment [Corrigendum]
Publicado: (2019)

Nasal high-flow in acute hypercapnic exacerbation of COPD [Corrigendum]
Publicado: (2019)

Repetitive Saliva Swallowing Test Predicts COPD Exacerbation [Corrigendum]
Publicado: (2021)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
Publicado: (2018)

Low Eosinophil Phenotype Predicts Noninvasive Mechanical Ventilation Use in Patients with Hospitalized Exacerbations of COPD [Corrigendum]
Publicado: (2022)

The Association Between Cognitive Functions and Psychological Factors in Patients with Severe COPD [Corrigendum]
Publicado: (2023)

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD [Corrigendum]
Publicado: (2014)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum]
Publicado: (2021)

Image-Enhanced Bronchoscopic Evaluation of Bronchial Mucosal Microvasculature in COPD [Corrigendum]
Publicado: (2022)

Sinonasal Symptoms in COPD: Burden and Associations with Clinical Markers of Disease [Corrigendum]
Publicado: (2022)

Efficacy and safety of indacaterol/glycopyrronium in Japanese patients with COPD: a subgroup analysis from the SHINE study [Corrigendum]
Publicado: (2017)

Life Expectancy with and without Cognitive Impairment in Seven Latin American and Caribbean Countries
por: Ashby-Mitchell, Kimberly, et al.
Publicado: (2015)

Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Publicado: (2021)

Corrigendum to “Safety and immunogenicity of mRNA-LNP COVID-19 vaccine CVnCoV in Latin American adults: A phase 2 randomized study” [Vaccine: X 11 (2022) 100189]
por: Sáez-Llorens, Xavier, et al.
Publicado: (2023)

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]
Publicado: (2017)

Corrigendum: Inpatient hypospadias care: Trends and outcomes from the American nationwide inpatient sample
por: Meyer, Christian, et al.
Publicado: (2015)

The use of mechanical restraint in Pacific Rim countries: an international epidemiological study—Corrigendum
por: Newton-Howes, G., et al.
Publicado: (2021)

Effect of Gender on Lung Function and Patient-Reported Outcomes in Patients with COPD Receiving Nebulized Glycopyrrolate [Corrigendum]
Publicado: (2021)

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia [Corrigendum]
Publicado: (2016)

The Short Physical Performance Battery is a discriminative tool for identifying patients with COPD at risk of disability [Corrigendum]
Publicado: (2016)

Impaired Training-Induced Adaptation of Blood Pressure in COPD Patients: Implication of the Muscle Capillary Bed [Corrigendum]
Publicado: (2020)

Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy [Corrigendum]
Publicado: (2022)

Cross-national measurement invariance of the Purpose in Life Test in seven Latin American countries
por: Caycho-Rodríguez, Tomás, et al.
Publicado: (2022)

Ultrafine particles in airways: a novel marker of COPD exacerbation risk and inflammatory status [Corrigendum]
Publicado: (2019)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020)

Clinical Impact and Healthcare Resource Utilization Associated with Early versus Late COPD Diagnosis in Patients from UK CPRD Database [Corrigendum]
Publicado: (2020)

Corrigendum to “Natural Treatment Systems as Sustainable Ecotechnologies for the Developing Countries”
por: Mahmood, Qaisar, et al.
Publicado: (2018)

Prognostic Role of NT-proBNP for in-Hospital and 1-Year Mortality in Patients with Acute Exacerbations of COPD [Corrigendum]
Publicado: (2020)

Cost-Effectiveness of Humidified High-Flow Therapy (HHFT) for COPD Patients on Long-Term Oxygen Therapy [Corrigendum]
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_40en6j4do2gpghb8v0v67lt8sr